Fueled by Growth, Alcami Unveils New Sales Office in Cambridge, MA

DURHAM, N.C.Feb. 13, 2018 /PRNewswire/ — Alcami Corporation, a leading provider of custom end-to-end development and manufacturing services for the pharmaceutical and biotechnology industries, today announces the opening of a new sales office in the heart of Cambridge, Massachusetts, the technology hub of the Boston metro area. The Kendall Square facility will support robust customer growth and connect Alcami to the forefront of hundreds of thriving pharma and biotech start-ups and innovators.

"We are delighted to expand our presence into Boston, a growing market for Alcami and for innovation," said Alcami CEO, President and Chairman, Dr. Stephan Kutzer. "Our goal is to be a leading science and technology solution provider, fostering the development and launch of life-saving medicines."

The new office at One Broadway, Cambridge, Massachusetts, is centrally located and in close proximity to some of the most prestigious academic institutions in the United States. It will be a hub for Alcami's global sales and business development organization, and be outfitted with the company's trademark VirtualLab™ experience, an immersive, state-of-the-art virtual ticket into Alcami's facilities across the globe.

Alcami already has plans to expand its new office into additional meeting spaces to facilitate project team meetings via video conference, offer quarterly educational forums as part of Venture Café Kendall's networking series, and host custom client events focused on drug development and launch.

"Our commercial organization is primed for historic growth and market penetration," said Alcami Chief Commercial Officer, Syed T. Husain. "We look forward to strengthening relationships with our increasing network of universities, clients and partners in the New England region and will continue to provide them with unparalleled responsive service and results."

SOURCE Alcami Corporation

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.